Overview

Decentralized Science (DeSci) is a movement to reform how science is funded, published, and governed using public blockchains, DAOs, and token incentives. As the Ethereum Foundation's DeSci hub frames it, the goal is to build public infrastructure for “funding, creating, reviewing, crediting, storing, and disseminating scientific knowledge” — addressing systemic failures of the traditional research system.

The problems DeSci targets

• Funding bottleneck — grant capital is scarce, slow, and gate-kept; low single-digit acceptance rates push researchers to optimize for grant committees rather than discovery.
• Closed-access publishing — publicly-funded results sit behind paywalls, and peer review is opaque and unpaid.
• IP lock-up — promising early research stalls in university tech-transfer offices, unable to attract capital or reach the public.
• Misaligned incentives — reproducibility and negative results are undervalued because they don't advance careers.

Core primitives

• IP-NFTs & IP Tokens — tokenize the legal rights to research so a community can own and fund it.
• DeSci DAOs — token holders collectively decide which research to fund and how to commercialize the results.
• Novel funding — quadratic funding, retroactive public-goods funding, and token-curated grants replace the single grant committee.
• Open, credited peer review — on-chain attestations give reviewers reputation and, increasingly, payment.

Why now: the 2025–26 public-funding shock

DeSci's funding-bottleneck thesis stopped being abstract in 2025. Over the year the U.S. government terminated or froze more than 3,800 NIH and NSF research grants — roughly $3 billion in unspent, already-committed funds, the NIH alone accounting for nearly 2,500 grants (about $2.3 billion). One analysis found the terminations disrupted roughly 1 in 30 active clinical trials, affecting more than 74,000 enrolled participants. When the dominant grant pipeline contracts this sharply, community- and token-based funding stops being a novelty and becomes a lifeline — the clearest demand-side tailwind DeSci has had.

The 2026 landscape

DeSci has consolidated around a few coordination layers. Bio Protocol — which describes itself as “DeSci's new financial layer” — now coordinates 10+ biotech DAOs across longevity, women's health, psychedelics and synthetic biology, having raised over $33M in its BIO Genesis round (Binance Labs' first DeSci investment, Nov 2024). At DeSci.Berlin in June 2026 it launched OpenLabs — backed by a fresh $6.9 million round — pairing AI-assisted project development with community funding votes in a single interface — a sign that DeSci's frontier is moving from tokenizing IP toward operating the full research workflow on-chain.

Relevance to Radix

Radix's asset-oriented programming is well-suited to DeSci: IP-NFTs are native resources (not contract state), DAOs benefit from engine-level access rules, and complex funding flows compose atomically via transaction manifests. See DeSci on Radix.

How Caper approaches this

A research collective doesn't need a bespoke platform to run the DeSci playbook. A caper gives any group a bonding-curve treasury to raise from supporters and a proposal system to direct that treasury toward a lab, a milestone, or an IP acquisition — with a participation-gated pro-rata exit so contributors who lose conviction can withdraw their share rather than being locked in. It's the same “community funds the science, community governs the outcome” loop that DeSci pioneered, without a research group having to deploy its own contracts. See DeSci funding.